Arcadia Biosciences, Inc. (RKDA) Operating income 2017–2025
Arcadia Biosciences, Inc. (RKDA) annual operating income history from SEC filings — each fiscal year as reported.
-$2.5MFY2025 · since FY2017: -$14.3M → -$2.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$2.5M | +31.5% |
| FY2024 | -$3.6M | +40.2% |
| FY2023 | -$6.1M | +56.4% |
| FY2022 | -$14.0M | +60.6% |
| FY2021 | -$35.5M | -178.0% |
| FY2020 | -$12.8M | +34.1% |
| FY2019 | -$19.4M | -14.9% |
| FY2018 | -$16.9M | -17.8% |
| FY2017 | -$14.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RKDA financial trends
RKDA RevenueRKDA Net incomeRKDA Net marginRKDA Gross profitRKDA Gross marginRKDA Operating marginRKDA Operating cash flowRKDA Free cash flowRKDA Capital expendituresRKDA Return on equityRKDA Stock buybacksRKDA Dividends paidRKDA Total assetsRKDA Total liabilitiesRKDA Shareholders’ equityRKDA overview →